These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 5115851

  • 1. Phase II study of strepozotocin (NSC-85998) in the treatment of advanced gastrointestinal cancer.
    Moertel CG, Reitemeier RJ, Schutt AJ, Hahn RG.
    Cancer Chemother Rep; 1971 Jun; 55(3):303-7. PubMed ID: 5115851
    [No Abstract] [Full Text] [Related]

  • 2. A phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC79037) in the palliative management of advanced gastrointestinal cancer.
    Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.
    Cancer Res; 1972 Jun; 32(6):1278-9. PubMed ID: 4113144
    [No Abstract] [Full Text] [Related]

  • 3. Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.
    Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.
    Cancer Res; 1972 Jun; 32(6):1280-2. PubMed ID: 5030827
    [No Abstract] [Full Text] [Related]

  • 4. Combination chemotherapy in gastrointestinal cancer.
    Reitemeier RJ, Moertel CG, Hahn RG.
    Cancer Res; 1970 May; 30(5):1425-8. PubMed ID: 4246651
    [No Abstract] [Full Text] [Related]

  • 5. 1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors.
    Wilson CB, Boldrey EB, Enot KJ.
    Cancer Chemother Rep; 1970 Aug; 54(4):273-81. PubMed ID: 4334089
    [No Abstract] [Full Text] [Related]

  • 6. Notes on streptozotocin in metastatic insulinoma.
    Vogel TT.
    J Surg Oncol; 1971 Aug; 3(5):481-5. PubMed ID: 4329781
    [No Abstract] [Full Text] [Related]

  • 7. Combination therapy with 5-fluorouracil (5-FU; NSC-19893) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for disseminated gastrointestinal carcinoma.
    Lokich JJ, Skarin AT.
    Cancer Chemother Rep; 1972 Oct; 56(5):653-7. PubMed ID: 4569058
    [No Abstract] [Full Text] [Related]

  • 8. Chemotherapy of metastatic gastrointestinal neoplasms with 5-fluorouracil and streptozotocin.
    Seligman M, Bukowski RM, Groppe CW, Weick JK, Hewlett JS, Greenstreet RL.
    Cancer Treat Rep; 1977 Oct; 61(7):1375-7. PubMed ID: 201379
    [No Abstract] [Full Text] [Related]

  • 9. [Results obtained in 6 cases of tumors treated with sarkomycin (an antitumoral antibiotic)].
    Sezer R.
    Turk Tip Cemiy Mecm; 1966 Mar; 32(3):131-40. PubMed ID: 4287509
    [No Abstract] [Full Text] [Related]

  • 10. 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer.
    van Eden EB, Falkson HC, Falkson G.
    Cancer Chemother Rep; 1970 Oct; 54(5):347-59. PubMed ID: 5514624
    [No Abstract] [Full Text] [Related]

  • 11. A trial of 1-(2-chlorethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea in the treatment of patients with advanced gastro-intestinal cancer.
    Giles GR, Hall R, Brennan TG, Worthy TS.
    Br J Surg; 1974 Dec; 61(12):950. PubMed ID: 4140746
    [No Abstract] [Full Text] [Related]

  • 12. "Big" insulin and the treatment of an islet cell carcinoma with streptozotocin.
    Pearson MJ, Larkins RG, Martin FI.
    Metabolism; 1972 Jun; 21(6):551-8. PubMed ID: 4337586
    [No Abstract] [Full Text] [Related]

  • 13. Oral administration of fluorouracil. A preliminary trial.
    Nadler SH.
    Arch Surg; 1968 Oct; 97(4):654-6. PubMed ID: 5678137
    [No Abstract] [Full Text] [Related]

  • 14. BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report.
    Walker MD, Hurwitz BS.
    Cancer Chemother Rep; 1970 Aug; 54(4):263-71. PubMed ID: 4946011
    [No Abstract] [Full Text] [Related]

  • 15. Phase II study of methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
    Engstrom PF, Catalano RB, Creech RH.
    Cancer Treat Rep; 1976 Mar; 60(3):285-7. PubMed ID: 1260784
    [No Abstract] [Full Text] [Related]

  • 16. Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.
    Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.
    Cancer Chemother Rep; 1972 Feb; 56(1):95-101. PubMed ID: 5030811
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of Hodgkin's disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Marsh JC, DeConti RC, Hubbard SP.
    Cancer Chemother Rep; 1971 Dec; 55(5):599-606. PubMed ID: 4334161
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU.
    Young RC, DeVita VT, Serpick AA, Canellos GP.
    N Engl J Med; 1971 Aug 26; 285(9):475-9. PubMed ID: 5558887
    [No Abstract] [Full Text] [Related]

  • 19. Patterns of intravenous glucose tolerance and insulin response before and after treatment with streptozotocin (NSC-85998) in patients with cancer.
    Sadoff L.
    Cancer Chemother Rep; 1972 Feb 26; 56(1):61-9. PubMed ID: 4260577
    [No Abstract] [Full Text] [Related]

  • 20. Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer.
    Klaassen DJ, Rapp E.
    Cancer Chemother Rep; 1974 Feb 26; 58(5 Pt 1):667-9. PubMed ID: 4426046
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.